Direct gene therapy for repair of the spinal cord

Journal of Neurotrauma
B Blits, Mary Bartlett Bunge

Abstract

For regrowth of injured nerve fibers following spinal cord injury (SCI), the environment must be favorable for axonal growth. The delivery of a therapeutic gene, beneficial for axonal growth, into the central nervous system for repair can be accomplished in many ways. Perhaps the most simple and elegant strategy is the so-called direct gene therapy approach that uses a single injection for delivery of a gene therapy vehicle. Among the vectors that have been used to transduce neural tissue in vivo are non-viral, herpes simplex viral, adeno-associated viral, adenoviral, and lentiviral vectors, each with their own merits and limitations. Many studies have been undertaken using direct gene therapy, ranging from strategies for neuroprotection to axonal growth promotion at the injury site, dorsal root injury repair, and initiation of a growth-supporting genetic program. The limitations and successes of direct gene transfer for spinal cord repair are discussed in this review.

References

Jan 1, 1990·Progress in Brain Research·F H GageT Friedmann
Nov 1, 1989·Journal of Virology·A D Kwong, N Frenkel
Feb 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·T D PalmerA D Miller
Oct 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·P L Hermonat, N Muzyczka
Jun 1, 1995·Neuroscience·A P ByrnesH M Charlton
Oct 1, 1994·Journal of Neurotrauma·S Varon, J M Conner
Apr 1, 1994·The Journal of Comparative Neurology·V E KoliatsosD L Price
Apr 1, 1996·Physiological Reviews·M E Schwab, D Bartholdi
Oct 15, 1996·Proceedings of the National Academy of Sciences of the United States of America·L NaldiniI M Verma
Mar 28, 1998·The European Journal of Neuroscience·L NovikovaJ O Kellerth
Jun 13, 1998·Journal of Neurotrauma·P A DijkhuizenJ Verhaagen
Jul 22, 1999·Clinical Immunology : the Official Journal of the Clinical Immunology Society·D G BrockstedtE G Engleman
Jun 6, 2000·Neuron·O BeharC J Woolf

❮ Previous
Next ❯

Citations

Oct 13, 2007·Pharmaceutical Research·Jamie M BergenSuzie H Pun
May 16, 2007·Journal of Neuroengineering and Rehabilitation·Ali Samadikuchaksaraei
May 17, 2008·Upsala Journal of Medical Sciences·Leif AnderbergAnders Holtz
Aug 7, 2010·Expert Opinion on Pharmacotherapy·Alex TselisRobert P Lisak
Aug 31, 2010·Journal of Controlled Release : Official Journal of the Controlled Release Society·Sejin SonWon Jong Kim
Dec 4, 2008·Journal of Tissue Engineering and Regenerative Medicine·N D JefferyD M Chari
Jul 19, 2012·Journal of Cellular and Molecular Medicine·Ana Paula PêgoEva Sykova
Apr 24, 2015·Journal of Biomedical Materials Research. Part a·So-Jung GwakYoon Ha
Apr 30, 2015·Biomarker Insights·Christopher M Walthers, Stephanie K Seidlits
Jul 22, 2006·Nature Reviews. Neuroscience·Sandrine ThuretFred H Gage
Jul 26, 2011·Journal of Biomaterials Science. Polymer Edition·So-Jung GwakYoon Ha
Oct 13, 2018·Tissue & Cell·Mirna Luciano de Gois da SilvaMaria Acelina Martins de Carvalho

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.